Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MWN101 in obese adults with obstructive sleep apnea (phase 2)
CTR20250212Phase 2Terminated
- Sponsor
- Shanghai Minwei Biotechnology Co., Ltd.
- Start
- Jan 2025
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of MWN101 in obesity, obstructive sleep apnea hypopnea syndrome (OSAHS), sponsored by Shanghai Minwei Biotechnology Co., Ltd.. Started Jan 2025; status: terminated.
02
Drugs
MWN101
03
Conditions
obesityobstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on CTR20250212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250212.